Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amifostine versus mycophenolate mofetil for relapsed and refractory immune thrombocytopenic purpura
ChiCTR-TRC-14004514Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Dalian Medical University
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of amifostine and mycophenolate mofetil in immune thrombocytopenia (ITP) (2 arms), sponsored by The First Affiliated Hospital of Dalian Medical University. Primary endpoint: Platelet count. Started Jun 2014; status: recruiting.
02
Drugs
amifostinemycophenolate mofetil
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on ChiCTR-TRC-14004514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14004514.